2022
DOI: 10.1016/s1120-1797(22)01466-1
|View full text |Cite
|
Sign up to set email alerts
|

FLASH in the Clinic Track (Oral Presentations) SHOOT-THROUGH PROTON FLASH FOR NEUROLOGICAL TUMORS LIMITS UNCERTAINTIES IN (BIOLOGICAL EFFECTIVE) DOSE

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…26 Another study has also highlighted the TB plan's superior robustness in terms of LET and range uncertainty. 27 These findings suggest the potential use of the TB plan in specific situations. Consequently, a comparison between BP and TB FLASH plans is conducted to provide further evidence for future clinical decisions.…”
Section: Introductionmentioning
confidence: 92%
See 1 more Smart Citation
“…26 Another study has also highlighted the TB plan's superior robustness in terms of LET and range uncertainty. 27 These findings suggest the potential use of the TB plan in specific situations. Consequently, a comparison between BP and TB FLASH plans is conducted to provide further evidence for future clinical decisions.…”
Section: Introductionmentioning
confidence: 92%
“…Meanwhile, the TB plan is well‐suited for the SFPF treatment schedule 26 . Another study has also highlighted the TB plan's superior robustness in terms of LET and range uncertainty 27 . These findings suggest the potential use of the TB plan in specific situations.…”
Section: Introductionmentioning
confidence: 93%